Cite
HARVARD Citation
Lok, S. et al. (2023). Pertuzumab study in the neoadjuvant setting for HER2‐positive nonmetastatic breast cancer in Australia (PeRSIA). International journal of cancer. 152 (2), pp. 267-275. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Lok, S. et al. (2023). Pertuzumab study in the neoadjuvant setting for HER2‐positive nonmetastatic breast cancer in Australia (PeRSIA). International journal of cancer. 152 (2), pp. 267-275. [Online].